National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors.
Carlos E Diaz-CastrillonLauren V HuckabyLucas WiterNicolas H PopeMarc R KatzPrabhakar K BaligaArman KilicPublished in: Clinical transplantation (2022)
Compared with recipients of HCV- donor dual heart-kidney transplants, recipients of HCV+ organs had comparable 1-year survival and clinical outcomes after combined transplantation. Although future studies should evaluate other outcomes related to HCV+ donor use, this practice appears safe and should be expanded further in the heart-kidney transplant population.